Advertisements

Elon Musk Explores Investment in Brain-Chip Startup Synchron Amid Neuralink Delays

by jingji18

Elon Musk has initiated discussions with brain-computer interface company Synchron about a potential investment, according to four sources familiar with the matter. This move comes as Musk’s own neurotechnology firm, Neuralink, faces regulatory delays in developing its brain-implant technology.

Details of the Potential Deal

Musk recently contacted Synchron founder and CEO Thomas Oxley to explore investment opportunities, though the nature of any potential collaboration remains unclear. Sources indicate Synchron, currently ahead in regulatory approvals, hasn’t committed to any agreement and discussions remain preliminary.

Advertisements

Regulatory Landscape

The Brooklyn-based Synchron has progressed further than Neuralink in securing FDA clearance for its medical devices. The company achieved a significant milestone last month by successfully implanting its device in a U.S. patient, following FDA approval for human trials and completed Australian studies.

Advertisements

Neuralink’s Challenges

Current and former Neuralink employees reveal Musk has expressed frustration with the company’s slower-than-expected progress. Neuralink, founded, initially projected regulatory approval but has yet to begin human trials in the U.S.

Advertisements

Company Comparisons

Synchron’s minimally invasive stent-like device contrasts with Neuralink’s skull-embedded chip technology. The startup has raised $65 million and employs 60 people, while Neuralink boasts 300 employees across two locations and $363 million in funding.

Advertisements

Industry Context

This isn’t Musk’s first engagement with competitors – he previously held talks with Paradromics Inc before abandoning discussions. Meanwhile, Synchron’s investor roster now includes former Neuralink president Max Hodak, who left the company last year.

Official Responses

Representatives for Musk and Neuralink declined to comment, as did Synchron’s spokesperson. The FDA hasn’t responded to inquiries about Neuralink’s application status.

Relation topics:

Advertisements

You may also like

DailyBlogWriting.com offers fresh, insightful content on various topics, providing readers with daily articles to inspire, inform, and entertain. From health tips to tech trends, we cover it all with a commitment to quality and engaging writing.

TAGS

Copyright © 2023 dailyblogwriting.com